EN DE
Watch Kaisa Health Group Holdings Ltd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Kaisa Health Group Holdings Ltd (0876) fair value: what the stock is really worth

As of Nov 5, 2026: fair value (intrinsic value) of Kaisa Health Group Holdings Ltd stock HK$1.53, price HK$1.46, upside +4.8%, quality 29 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare HK · ISIN BMG522111027

KH Kaisa Health Group Holdings Ltd logo Thin data Nov 11, 2026

Kaisa Health Group Holdings Ltd

0876 · HK
Fairly valued, weak quality

The stock costs about what our calculation considers fair.

Low debt
Fair value HK$1.53 · Fairly valued
Revenue last quarter 16% below a year ago.
Quality 29/100
Weak Growth (revenue 5y −5.4 %/yr in HKD)
Loss-making · -115.9% net margin (TTM)
Negative free cash flow
Trails peers (3/10)
Narrow moat 12/100
Thin data
EstimateData corrected by AI research
Watch Kaisa Health Group Holdings Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

HK$20.00 HK$0.0480 Fair Value HK$1.53 Sep 2020 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 11, 2026.

How to read this chart

60‑month range HK$0.0480 – HK$20.00 · fair‑value band HK$1.15 – HK$1.92 · the HK$1.46 price screens below the HK$1.53 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 11, 2026.

Follow Kaisa Health Group Holdings in your weekly email

Every Wednesday you see whether Kaisa Health Group Holdings is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Kaisa Health Group Holdings Limited, an investment holding company, engages in the health care and dental business in the People's Republic of China and internationally.

Show moreShow less

It produces and sells dental prosthetics, including crowns and bridges, removable full and partial dentures, implants, and full-cast restorations, as well as provides sport rehabilitation services comprising postoperative rehabilitation, sports injury rehabilitation, chronic pain, scoliosis, deformity correction, and other rehabilitation services; and health leisure services.

The company is also involved in the investment holding of loan receivable; provision of medical consultation and other medical services; and trading and provision of medical technology development. In addition, it trades in dental prosthetics, implant instruments, and other dental products.

The company was formerly known as Mega Medical Technology Limited and changed its name to Kaisa Health Group Holdings Limited in January 2018. Kaisa Health Group Holdings Limited was founded in 1971 and is headquartered in Central, Hong Kong.

Stock analysis

Kaisa Health Group Holdings Ltd (0876) currently trades at HK$1.46, while our estimate is HK$1.53, so the stock looks roughly fairly valued today (gap 4.6%).

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: HK$1.15 (bear) to HK$1.92 (bull), the price of HK$1.46 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 29/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Kaisa Health Group Holdings Ltd reported revenue of HK$139M in FY2025 versus HK$210M in FY2021, a compound −9.7%/yr. Reported net income was −HK$46.7M in FY2025.

Key figures

Market cap HK$151M (≈ $19.3M) Micro · P/S ratio 1.77 · Net margin −33.6% · Return on equity −71.8% · Return on assets (EBIT) −7.5% (5-year average) · Operating margin −10.8% · Revenue (TTM) HK$85.5M · Revenue growth (YoY) −15.9%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (medium confidence).

What moves the price

The share trades about 86% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −42% fair-value upside, at 5%, 0876 screens cheaper than that median.

Fair Value

Bear HK$1.15 Fair Value HK$1.53 Bull HK$1.92
Price HK$1.46 · Upside +4.8%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 29/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 6
How much profit the company makes from its sales and capital
Quality Growth 12
Are margins and returns getting better?
Cashflow 11
Do the profits arrive as real cash?
Financial strength 66
Debt, balance sheet and risk of trouble
Investment 89
Does it invest with discipline instead of growing at any price?
Low Volatility 27
How calm the share price moves, does not count
Price momentum 0
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−24.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−10.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.4%
Start year 2020 (pandemic). Over 10 years: +3.4% a year
Revenue growth 25 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.8%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−41.0% (2020) → −39.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch 0876, get fair value alerts →

Compare Kaisa Health Group Holdings Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 197 stocks

Beats the industry median on 3/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 29 · Bottom 25%
Fair Value upside +4.8% · Above median
Profitability
Return on assets −9.9% · Bottom 25%
Net margin (12 months) −115.9% · Bottom 25%
Operating margin (12 months) −10.8% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −15.9% · Bottom 25%
Balance sheet
Debt / equity 0.25× · Above median

Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper

P/B 0.38× · Cheapest 25%
P/S (12 months) 1.77× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)40 · sector 18
FUTURE (revenue growth)0 · sector 39
PAST (return on equity)0 · sector 26
HEALTH (low debt)88 · sector 96
DIVIDEND (yield)0 · sector 31

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Solventum Corporation SOLV $88.62 $131.27 +48% vs 0876
EssilorLuxottica Société anonyme EL €182.55 €196.22 +7% vs 0876
Intuitive Surgical, Inc ISRG $449.53 $353.90 −21% vs 0876
Medline Inc MDLN $42.16 $28.59 −32% vs 0876
Alcon Inc ALC CHF 59.48 CHF 34.29 −42% vs 0876
Becton, Dickinson and Company BDX $214.52 $97.80 −54% vs 0876
Straumann Holding STMN CHF 106.65 CHF 45.50 −57% vs 0876
West Pharmaceutical Services, Inc WST $412.86 $139.22 −66% vs 0876
Sartorius Stedim Biotech S.A DIM €226.80 €54.82 −76% vs 0876
Sartorius Aktiengesellschaft SRT €229.00 €42.50 −81% vs 0876

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Average Down CalculatorFree calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Kaisa Health Group Holdings Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Kaisa Health Group Holdings Ltd Fair Value". https://www.fairvalue-calculator.com/stock/0876

Frequently asked questions

Is Kaisa Health Group Holdings Ltd (0876) overvalued or undervalued?
As of Nov 11, 2026, our estimate of fair value is HK$1.53 versus the last price from Nov 5, 2026 of HK$1.46, about +5% upside (fairly valued).
What is the fair value of 0876?
Our estimate for Kaisa Health Group Holdings Ltd is HK$1.53 (as of Nov 11, 2026), built from audited fundamentals. Last price (from Nov 5, 2026): HK$1.46.
What is the quality score of 0876?
Kaisa Health Group Holdings Ltd has a Quality Score of 29/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Kaisa Health Group Holdings Ltd (0876)?
Our calculated price target is the estimate of HK$1.53 (as of Nov 11, 2026). Cautious scenario HK$1.15, optimistic scenario HK$1.92. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Kaisa Health Group Holdings Ltd stock forecast for 2026?
Our estimate puts fair value at HK$1.53, about +5% upside versus the last price from Nov 5, 2026 of HK$1.46 (fairly valued). Cautious scenario HK$1.15, optimistic scenario HK$1.92. The calculation is refreshed regularly with new filings.
What is the revenue of Kaisa Health Group Holdings Ltd (0876)?
Kaisa Health Group Holdings Ltd reported trailing-twelve-month revenue of about HK$85.5M (latest available figure, as of Nov 11, 2026).
What is the intrinsic value of Kaisa Health Group Holdings Ltd (0876)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Kaisa Health Group Holdings Ltd it is HK$1.53 per share (as of Nov 11, 2026), against a price of HK$1.46.
Is Kaisa Health Group Holdings Ltd stock overvalued or undervalued in 2026?
As of Nov 11, 2026, 0876 trades below its calculated fair value: price HK$1.46, fair value HK$1.53, a gap of about +5% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0876?
No. The price is what the market pays today (HK$1.46); the fair value is what the company's own numbers justify (HK$1.53). For Kaisa Health Group Holdings Ltd the two are HK$0.0700 per share apart. That gap is exactly why we show both numbers side by side.
How much is Kaisa Health Group Holdings Ltd worth?
The market values Kaisa Health Group Holdings Ltd at about HK$151M (market capitalisation, as of Nov 11, 2026). Per share that is HK$1.46; our models calculate a fair value of HK$1.53 per share.
What do the bullish and bearish scenarios say about 0876?
Our models span a range for Kaisa Health Group Holdings Ltd: cautious scenario HK$1.15, base HK$1.53, optimistic HK$1.92 per share (as of Nov 11, 2026, price HK$1.46). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Kaisa Health Group Holdings Ltd (0876)?
Balance-sheet figures for Kaisa Health Group Holdings Ltd (as of Nov 11, 2026): return on equity −71.8%, debt of 0.25 per unit of equity. They feed the Quality Score of 29/100, which measures business quality independently of the share price.
How far is 0876 from its 52-week high?
Kaisa Health Group Holdings Ltd trades at HK$1.46, about 86% below its 52-week high of HK$10.50 and at the low of HK$1.46 (as of Nov 11, 2026). Distance from the high says nothing about value: that is what the fair value of HK$1.53 is for.
Which stocks are comparable to Kaisa Health Group Holdings Ltd?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Becton, Dickinson and Company, Medline Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Kaisa Health Group Holdings Ltd stock attractive at the current price?
The data as of Nov 11, 2026: price HK$1.46, calculated fair value HK$1.53 (+5%), Quality Score 29/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0% above its aggregate fair value. Kaisa Health Group Holdings Ltd currently trades 5% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Kaisa Health Group Holdings Ltd (0876)?
The latest price we hold is from Nov 5, 2026 and stands at HK$1.46. Our estimate is HK$1.53, about +5% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Kaisa Health Group Holdings Ltd right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Kaisa Health Group Holdings Ltd

How large is the market capitalisation of Kaisa Health Group Holdings Ltd (0876)?
The market capitalisation of Kaisa Health Group Holdings Ltd is HK$151M (≈ $19.3M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Kaisa Health Group Holdings Ltd (0876)?
The price-to-sales ratio of Kaisa Health Group Holdings Ltd is 1.77 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Kaisa Health Group Holdings Ltd (0876)?
The net margin of Kaisa Health Group Holdings Ltd is −33.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Kaisa Health Group Holdings Ltd (0876)?
The return on equity (ROE) of Kaisa Health Group Holdings Ltd is −71.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Kaisa Health Group Holdings Ltd (0876)?
On an EBIT basis the return on assets of Kaisa Health Group Holdings Ltd is −7.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Kaisa Health Group Holdings Ltd (0876)?
The operating margin of Kaisa Health Group Holdings Ltd is −10.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Kaisa Health Group Holdings Ltd (0876)?
Revenue at Kaisa Health Group Holdings Ltd is growing −15.9% versus a year earlier (3y avg −10.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Kaisa Health Group Holdings Ltd (0876)?
Earnings per share at Kaisa Health Group Holdings Ltd are growing +433% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Kaisa Health Group Holdings Ltd (0876) generate?
The free cash flow of Kaisa Health Group Holdings Ltd is −HK$58.4M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Kaisa Health Group Holdings Ltd (0876) hold?
Kaisa Health Group Holdings Ltd holds more cash than debt, HK$96.1M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Kaisa Health Group Holdings Ltd in the live analysis

One click puts Kaisa Health Group Holdings Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.